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reduce post-operative pain in these patients. We aim to assess the
efﬁcacy and safety of liposomal bupivacaine inﬁltration on the BMG
harvest site in alleviating pain by evaluating the post-operative pain
score, narcotic requirement and associated morbidities.
METHODS: After IRB approval, a single-blinded randomized
controlled trial was conducted among adult patients with urethral
stricture, that were evaluated suitable for substitution urethroplasty
using BMG. Patients were randomized using computer generated
allocation scheme to group 1 (liposomal bupivacaine) and group 2
(control). Patient demographic and peri-operative data were collected.
Outcome assessed were: post-operative day 1 -2 narcotic use,
converted as cumulative morphine equivalents on a 24-hour basis. A
validated survey with 10-point visual analogue scale for evaluation of
patient reported oral pain score, associated oral morbidities, and oral
conditions on post-procedural day 1-3 and 1-month follow-up. Fisher-
exact test and independent T-test was used to analyze the data with
statistical signiﬁcance set at 0.05 level. (Clinicaltrials.gov registration
NCT03720223)
RESULTS: A total of 50 eligible patients were enrolled, 7 were
excluded according to predeﬁned exclusion criteria (Group 1: 21, Group
2: 22). No signiﬁcant baseline characteristics difference was noted
between the treatment groups. Compared to group 2, a signiﬁcantly
lesser narcotic requirement was noted among the patients in group 1 on
post-op day 1 (IV Morphine equivalent mean difference 8.58; 95%CI
1.59, 15.56, p[0.017). No signiﬁcant between group difference was
noted for narcotic requirements on post-op day 2. Likewise, no
between group difference was noted for post-procedural oral pain
score, and oral morbidities on post-op day 1 to 3, and at 1-month
follow-up. For post-procedural oral conditions, a signiﬁcantly higher
number of patients in group 1 have reported oral numbness at post-
op day 2 (14 (87.5%) vs 8 (44.4%); p[0.013), which was not
sustained and equivalent to group 2 at 1-month follow-up.
CONCLUSIONS: Our study showed that Liposomal bupiva-
caine inﬁltration to the BMG harvest site is safe and may adequately
address the post-procedural oral pain, with noted signiﬁcantly fewer
narcotic requirements at post-op day 1. Although, higher incidence of
oral numbness can be reported among these patients on post-op day
2, which was not long-lasting. Future studies may consider to
evaluate the cost-effectiveness to determine suitability for routine use.
Source of Funding: None
MP55-09
ENDOSCOPIC TREATMENTS PRIOR TO URETHROPLASTY:
TRENDS IN MANAGEMENT OF URETHRAL STRICTURE DISEASE
SINCE THE AUA GUIDELINE
Matthew Moynihan*, Burlington, MA; Jeremy Myers, Salt Lake City, UT;
Sean Elliott, Minneapolis, MN; Bradley Erickson, Iowa City, IA;
Thomas Smith, Houston, TX; Jill Buckley, San Diego, CA; Lee Zhao,
New York City, NY; Bryan Voelzke, Seattle, WA; Nejd Alsikaﬁ, Gurnee,
IL; Benjamin Breyer, San Francisco, CA; Alex Vanni, Burlington, MA
INTRODUCTION AND OBJECTIVES: Endoscopic treatment of
urethral stricture disease (USD) continues to be the most common
treatment of USD despite its poor success compared to urethroplasty.
AUA guidelines regarding the management of male USD were pre-
sented in May 2016, advocating consideration of urethroplasty in pa-
tients with 1 prior failed endoscopic treatment. The aim of our study is to
determine if the number of endoscopic treatments of USD prior to
urethroplasty has decreased since the implementation of the AUA
guideline.
METHODS: A retrospective review of a prospectively main-
tained, multi-institutional urethral stricture database of high volume,
geographically diverse institutions was performed. We evaluated pre-
urethroplasty endoscopic treatment patterns prior to and after the
AUA male stricture guideline.
RESULTS: 2,964 urethroplasties were reviewed in 10 in-
stitutions. The overall average number of endoscopic treatments prior to
urethroplasty for the entire cohort was 2.15 (SD[ 4.887). There was a
decrease in the number of endoscopic treatments prior to urethroplasty
in the pre-May 2016 compared to post-May 2016 cohorts both for
overall urethroplasties (2.3 vs 1.6, P[0.0012) and anterior
urethroplasties speciﬁcally (2.6 vs 1.9, P[0.0026).
CONCLUSIONS: This is the ﬁrst study to demonstrate a
decrease in the number of endoscopic treatments of USD prior to
urethroplasty since development of the AUA stricture guideline. Further
research is needed to determine if there will be a continued trend in the
declining use of endoscopic treatment and elucidate the barriers to
earlier urethroplasty in patients with USD.
Source of Funding: None
MP55-10
UTILIZATION OF ENDOSCOPIC MANAGEMENT FOR URETHRAL
STRICTURES IN AQUA
Andrew J Cohen*, San Francisco, CA; Danil Makarov, New York, NY;
Matthew Cooperberg, San Francisco, CA; Raymond Fang, Linthicum,
MD; Benjamin N. Breyer, San Francisco, CA
INTRODUCTION AND OBJECTIVES: Repeated endoscopic
management of urethral strictures has poor long-term success. Recent
AUA guidelines on urethral stricture disease encourage early
urethroplasty. Contemporary patterns of urethral stricture disease
management and the affect of the AUA guidelines on them are poorly
understood. We hypothesized that practices with greater numbers of
urethral stricture patients would be likely to perform frequent DVIU.
METHODS: We queried the AQUA database using a combi-
nation of Current Procedural Terminology (CPT) codes and Interna-
tional Statistical Classiﬁcation of Diseases (ICD) 9/10 codes to identify
patients with urethral stricture and how they were managed. We
calculated total patient volume at the practice level as well as frequency
of direct vision internal urethrotomy (DVIU) and urethroplasty.
RESULTS: We identiﬁed 77,742 unique patients diagnosed
with urethral stricture in AQUA since 2014. Caucasians accounted for
75.4% of patients. The patients were cared for by 1343 providers at 171
practices. There was wide variation in utilization of DVIU (Figure 1) at
both the practice-level and the provider level, where we noted a 20-fold
variation. On average, practices performed 0.54 urethroplasties vs. 7.8
DVIU procedures. There was a positive correlation between a greater
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practice utilization of DVIU and increased urethroplasty volumes
(correlation coefﬁcient þ0.80).
CONCLUSIONS: DVIU is utilized signiﬁcantly more frequently
than urethroplasty. There is wide variation in the utilization of DVIU
across practices and providers. Future research should determine
whether this variation is guideline concordant or driven by variation in
case mix. On the other hand, this care may be guideline discordant and
driven by a lack of knowledge or by speciﬁc patient or physician
preferences.
Source of Funding: Institutional Funds
MP55-11
TEMPORAL TRENDS IN THE INCIDENCE OF PELVIC FRACTURE
ASSOCIATED URETHRAL INJURIES IN UNITED STATES
Hanson Zhao, Colby P. Souders, Andrew Chen*, Catherine Bresee,
D. Joseph Thum, Los Angeles, CA; Alex Hannemann, Vermillion, SD;
Jennifer T. Anger, Los Angeles, CA; George D. Webster, Durham, NC
INTRODUCTION AND OBJECTIVES: Pelvic fracture associ-
ated urethral injuries (PFUIs) can cause signiﬁcant patient morbidity.
The management of these patients is complex and can result in lifelong
consequences in the forms of stricture, incontinence, and erectile
dysfunction. There is a large discrepancy in the prevalence and etiol-
ogies of PFUIs between different countries, which is related to differ-
ences motor vehicle regulations, seat belt laws, and trafﬁc
infrastructure. In the United States, statewide seat belt laws were
passed from 1984-1995 and airbag requirements went into effect in
1998. We use a large contemporary population based cohort to assess
the temporal trend in PFUIs after these regulations.
METHODS: The National Inpatient Sample (NIS) is a weighted
sample of inpatient hospital discharge data with ICD-9 procedure and
diagnosis codes. Pelvic fractures were identiﬁed by any of the 808.xx
ICD-9 diagnosis codes. PFUI was identiﬁed by the combination of an
808.xx diagnosis code with an ICD-9 procedure code for suprapubic
tube placement (either code 57.17 or 57.18). SAS v9.2 software was
used to analyze frequencies. All data were analyzed with trend
weights provided by the NIS to account for changes in the study
design over time using years 1998-2014.
RESULTS: Average age was 38 years. 784 (11.5%) patients
were female. 654 patients (9.6%) died while hospitalized. There was
downward trend in the annual incidence of PFUI in the time frame
studied. The incidence of PFUI signiﬁcantly decreased from 1.7  0.2
cases per 100,000 hospital discharges in 1998 to 0.7  0.1 cases per
100,000 in 2011 (p[0.0067). The incidence appears to have stabilized
from 2011 to 2014. In the time frame studied, National Highway Trafﬁc
Safety Administration surveys demonstrated that seat belt use
increased from 58% to 87%.
CONCLUSIONS: While the true incidence of PFUI is likely
underestimated in this study, we demonstrate a decreasing trend in the
incidence of PFUI in the United States from 1998 to 2014. This occurred
after mandatory seat belt and airbag motor vehicle regulations that were
implanted in the 1990s. This decrease does, however, result in fewer
opportunities to train reconstructive surgeons in complex posterior
urethroplasty.
Source of Funding: none
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IMPACT OF PATIENT AND PROVIDER CHARACTERISTICS ON
RECURRENCE FOLLOWING URETHROPLASTY
Anthony Yang*, Michael Palese, New York, NY
INTRODUCTION AND OBJECTIVES: We aim to characterize
and determine predictors of urethral stricture recurrence following ure-
throplasty. This is the largest study to evaluate predictors of recurrence
and ﬁrst to include provider characteristics.
METHODS: Patient who underwent urethroplasty between
1995 and 2015 were identiﬁed from the Statewide Planning and
Research Cooperative System (SPARCS) database, a comprehensive
all-payer reporting system containing patient level data on all hospital
discharges in New York State. Recurrence and repeat urethroplasty
were identiﬁed by linking subsequent discharges. The chi-square test
was used to compare variables. Multivariable logistic regression was
used to determine predictors of recurrence and repeat urethroplasty.
RESULTS: 1,481 patients undergoing urethroplasty were
identiﬁed between 1995 and 2015. 1,285 (87%), 132 (9%) and 64 (4%)
underwent primary anastomosis, buccal graft and other graft ure-
throplasty, respectively. 158 (11%) patients experienced recurrence,
and of these patients, 95 (6%) underwent repeat urethroplasty. The
average time from the initial urethroplasty to recurrence and repeat
urethroplasty were 848 and 808 days, respectively. The majority
(53.8%) of recurrence occurred within 1 year. Multivariable analysis
demonstrated that risk factors for urethral stricture recurrence were race
(OR black vs. white: 1.77, CI: 1.1, 2.8, p[0.014), age (OR: 1.01, CI: 1,
1.03, p[0.001) and income (OR: 25-50th percentile vs top quartile:
1.69, CI: 1.01, 2.83, p[0.044). Of the patients with recurrence, insur-
ance (OR Medicaid vs. private insurance: 0.25, CI: 0.07, 0.86,
p[0.027) was the only predictor of urethroplasty. Other patient char-
acteristics, provider characteristics and use of graft did predict
recurrence.
CONCLUSIONS: Urethroplasty is a robust treatment for ure-
thral stricture with 91% of patients requiring only primary repair without
the need for second stage or repeat urethroplasty. Predictor of recur-
rence include race, age and income. Graft usage, surgeon volume and
hospital characteristics are not associated with recurrence.
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